Todd C Brady's Net Worth
$10.6 Million
Who is Todd C Brady?
Todd C Brady has an estimated net worth of $10.6 Million. This is based on reported shares across multiple companies, which include Aldeyra Therapeutics, Inc., Oncobiologics, Inc., Avidity Biosciences, Inc., Spring Bank Pharmaceuticals, Inc., and Evoke Pharma Inc.
SEC CIK
Todd C Brady's CIK is 0001579179
Past Insider Trading and Trends
2019 was Todd C Brady's most active year for acquiring shares with 19 total transactions. Todd C Brady's most active month to acquire stocks was the month of February. 2020 was Todd C Brady's most active year for disposing of shares, totalling 7 transactions. Todd C Brady's most active month to dispose stocks was the month of October. 2019 saw Todd C Brady paying a total of $592,551.41 for 709,017 shares, this is the most they've acquired in one year. In 2023 Todd C Brady cashed out on 401,869 shares for a total of $639,715.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aldeyra Therapeutics, Inc. (ALDX) Snapshot price: $6.13
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.07% | -183.24K |
$3.17 | -$580,759.68 | 1.47M |
Mar 9 - Mar 12
| |||
Form 4
| +13.69% | 199.25K |
$3.89 | -$382,158.52 | 1.65M |
Sep 7
| |||
Form 4
| +19.63% | 238.75K |
—
|
—
| 1.46M |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
| +1.48% | 17.7K |
$3.36 | $59,546.34 | 1.22M |
Jun 23
| |||
Form 4
| +26.35% | 250K |
—
|
—
| 1.2M |
Mar 30
| |||
Form 4
| +5.17% | 46.62K |
—
|
—
| 948.84K |
Apr 12
| |||
Form 4
| +38.33% | 250K |
—
|
—
| 902.22K |
Mar 2
| |||
Form 4
| +3.16% | 20K |
$5.10 | $101,908.00 | 652.22K |
Dec 16
| |||
Form 4
| +1.40% | 8.71K |
$5.68 | $49,483.25 | 632.22K |
Scheduled
|
Sep 30
| ||
Form 4
| +1.41% | 8.68K |
$5.81 | $50,432.54 | 623.51K |
Scheduled
|
Sep 23
| ||
Form 4
| +2.38% | 14.29K |
$5.91 | $84,464.94 | 614.83K |
Sep 18
| |||
Form 4/A
| +3.72% | 21.55K |
$5.91 | $127,448.68 | 600.54K |
Sep 13 - Sep 16
| |||
Form 4
| +2.25% | 13K |
$5.85 | $75,990.00 | 591.99K |
Sep 13 - Sep 16
| |||
Form 4
| +3.58% | 20K |
$5.14 | $102,824.00 | 578.99K |
Sep 9 - Sep 10
| |||
Form 4
| +81.68% | 250K |
—
|
—
| 556.05K |
Mar 5
| |||
Form 4
| +50.33% | 101.27K |
—
|
—
| 302.48K |
Mar 6
| |||
Form 4
| +212.41% | 136.81K |
—
|
—
| 201.21K |
Mar 3
| |||
Form 4
| +52.68% | 22.22K |
$4.50 | $100,003.50 | 64.41K |
Feb 17
| |||
Form 4
| +179.57% | 27.1K |
—
|
—
| 42.19K |
May 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +482.81% | 12.5K |
$8.00 | $100,000.00 | 15.09K |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncobiologics, Inc. (OTLK) Snapshot price: $7.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
| 182.27K |
Nov 9
| |||
Form 4
| +114.43% | 66.33K |
—
|
—
| 124.3K |
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avidity Biosciences, Inc. (RNA) Snapshot price: $40.46
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spring Bank Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.00K |
$7.12 | -$106,828.48 |
0
|
Nov 20 - Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
| +18.19% | 9.23K |
—
|
—
| 60.02K |
Sep 30
| |||
Form 4
| +19.87% | 8.42K |
—
|
—
| 50.78K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +45.79% | 13.31K |
—
|
—
| 42.36K |
Mar 31
| |||
Form 4
| +36.90% | 7.83K |
—
|
—
| 29.06K |
Dec 31
| |||
Form 4
| +20.41% | 3.6K |
—
|
—
| 21.23K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
| +23.50% | 3.35K |
—
|
—
| 17.63K |
Jun 28
| |||
Form 4
| +9.01% | 1.18K |
—
|
—
| 14.27K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +6.96% | 852 |
—
|
—
| 13.09K |
Jan 2
| |||
Form 4
| +5.45% | 633 |
—
|
—
| 12.24K |
Oct 2
| |||
Form 4
| +5.88% | 645 |
—
|
—
| 11.61K |
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 10.96K |
$9.12 | $99,991.68 | 10.96K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evoke Pharma Inc (EVOK) Snapshot price: $3.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 4
|
∞
| 4K |
$5.70 | $22,801.60 | 4K |
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||